Keyphrases
Diphtheria
100%
Corynebacterium Diphtheriae
90%
Group A Streptococcus
83%
Streptococcus Pyogenes (S. pyogenes)
69%
Group B Streptococcus
47%
Diphtheria Toxin
44%
Ribotyping
41%
United Kingdom
40%
Epidemiology
33%
Invasive Disease
30%
Europe
30%
Toxigenic Corynebacteria
29%
Non-toxigenic
29%
Group B Streptococcus Infection
29%
Wales
28%
Mycobacterium Ulcerans
25%
Streptococcus Pneumoniae
23%
Streptococcus Agalactiae
21%
Lancefield
21%
Toxigenic
17%
Corynebacterium
17%
Pulsed-field Gel Electrophoresis
17%
M Protein
17%
M-type
17%
Emm Type
17%
Ulcerans
16%
Penicillin
16%
Streptococcus Equi
14%
Erythromycin Resistance
14%
Enzyme-linked Immunosorbent Assay (ELISA)
13%
Streptococcus Pyogenes Infections
12%
Erythromycin
12%
Tetracycline
11%
Molecular Characterization
11%
Protein Antigen
11%
Pharyngitis
11%
Group G Streptococci
11%
Molecular Typing
11%
Group A Streptococcal Infection
11%
Whole Genome Sequencing
10%
Streptococcal Infection
10%
Molecular Epidemiology
10%
Pneumococcus
10%
Desmitis
9%
Invasive Infection
9%
Live Birth
9%
Restriction Fragment Length Polymorphism
9%
Core Genome multilocus Sequence Typing (cgMLST)
9%
Elek Test
9%
Necrotizing Fasciitis
9%
Immunology and Microbiology
Corynebacterium diphtheriae
79%
Serotype
78%
Streptococcus pyogenes
60%
Streptococcus Group A
41%
Streptococcus Agalactiae
39%
Corynebacterium
30%
Streptococcus
27%
Corynebacterium ulcerans
26%
Diphtheria Antibody
24%
Streptococcus Pneumonia
22%
Biovar
18%
Neutralization
17%
Antitoxin
13%
Ribotyping
12%
Antimicrobial Resistance
12%
Infectious Agent
12%
Streptococcus Group G
12%
Pharyngitis
12%
Multilocus Sequence Typing
11%
Enzyme-Linked Immunosorbent Assay
11%
Whole Genome Sequencing
11%
Amplified Fragment Length Polymorphism
10%
Penicillin
10%
Lineages
10%
Molecular Typing
9%
Streptococcus Dysgalactiae Subsp. Equisimilis
9%
Superantigen
9%
Single Nucleotide Polymorphism
8%
Meningitis
8%
Gene Sequence
8%
Prevalence
7%
Microbiology
7%
Minimum Inhibitory Concentration
7%
Infectious Disease
7%
Case Fatality Rate
7%
Awareness
7%
Antiserum
6%
Pneumococcus
6%
Necrotizing Fasciitis
6%
Exotoxin
6%
Pathogenicity Factor
6%
Real Time Polymerase Chain Reaction
6%
Conjugate Vaccine
6%
Antigen-Antibody Interaction
6%
Enzyme Immunoassay
6%
Cladistics
6%
Human Pathogen
5%
Pneumococcal Vaccine
5%
Booster Dose
5%
Virulence Factor
5%